Viewing Study NCT05705492

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2026-02-02 @ 6:27 PM
Study NCT ID: NCT05705492
Status: RECRUITING
Last Update Posted: 2025-04-06
First Post: 2023-01-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
Sponsor: OHSU Knight Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignant Solid Neoplasm View
None Advanced Biliary Tract Carcinoma View
None Advanced Esophageal Carcinoma View
None Metastatic Esophageal Carcinoma View
None Locally Advanced Biliary Tract Carcinoma View
None Locally Advanced Colorectal Carcinoma View
None Locally Advanced Esophageal Carcinoma View
None Locally Advanced Gastric Carcinoma View
None Metastatic Colorectal Carcinoma (mCRC) View
None Advanced Lung Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer View
None cachexia View
None weight loss View
None loss of appetite View